ATYR vs ADPT โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ATYR Captures Institutional Edge (2โ1 Pillars ยท 3โ5 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to aTyr Pharma, Inc. Common Stock (ATYR) driven by superior Growth & Margin, Momentum & Technical while ADPT counters with relative strength in Options & Structure. Fundamentally, ATYR trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus ADPT at N/M Forward P/E and -16.2% operating margin (-10.7% YoY). In options structure, ATYR sits in UNCLASSIFIED (36th %ile IV; Dealer Gamma Walls on Pro) against ADPT sits in BREAKOUT (36th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | ATYR Revenue | ADPT Revenue | ATYR Op. Margin | ADPT Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | N/A | $60M | N/A | -89.4% | ADPT |
| FY2019 | $0M | $90M | -5445.0% | -92.1% | ADPT |
| FY2020 | $10M | $100M | -152.2% | -155.3% | ATYR |
| FY2021 | N/A | $150M | N/A | -135.4% | ADPT |
| FY2022 | $10M | $190M | -446.8% | -108.0% | ADPT |
| FY2023 | $0M | $170M | -15557.8% | -133.3% | ADPT |
| FY2024 | $0M | $180M | -28899.6% | -90.8% | ADPT |
| FY2025 | $0M | $280M | -40856.3% | -20.6% | ADPT |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | ATYR | ADPT | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $15.6M | $4.7B | Larger Scale | ADPT |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +0.0% | -10.7% | Higher Growth | ATYR |
| Operating Margin (TTM) Profitability | 0.0% | -16.2% | Higher Margin | ATYR |
| Net Profit Margin Profitability | 0.0% | -23.7% | Higher Margin | ATYR |
| Return on Equity (ROE) Capital Efficiency | -93.7% | -36.4% | Higher ROE | ADPT |
| 52-Week Range Position Momentum | 62% ($0โ$8) | 82% ($12โ$32) | Stronger Trend | ADPT |
| Beta / 30D Volatility Risk Regime | -9.67ฮฒ ยท 13806% Vol | 1.73ฮฒ ยท 59% Vol | Lower Realized Risk | ADPT |
| Unified Institutional Score Composite Signal | 34.3 / 100 (SELL) | 43.2 / 100 (HOLD) | Higher Composite | ADPT |